No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Recce Receives Ethics Committee Nod to Allow Patients Access to Topical Gel Treatment
Recce to Raise $15.8M in Placement and Entitlement Offer to Fund Trials
Recce Pharmaceuticals Ltd: Appendix 4D and Interim Financial Report
Recce Pharmaceuticals Obtains Japan Patent for Anti-Infectives
Recce Pharmaceuticals Releases Positive Data From Phase II Trial of Topical Gel for Skin Infections
Recce Pharmaceuticals' Phase 2 Trial Shows Topical Gel Safe, Well-Tolerated